ContraFect is a biotechnology company pioneering the use of monoclonal antibodies to treat life-threatening infectious diseases.
|
|
|
|
|
11-50 employees
View all ContraFect employees
|
|
|
Biotechnology Research
|
|
|
9142072300
|
|
|
New York, New York
|
|
|
2008
|
Keren Marshal is the CEO of ContraFect. To contact Keren Marshal email at [email protected] or [email protected]. Or you may call 9142315904
The decision makers in ContraFect are Abe Thariath, Abraham Thariath, Alan Potts, etc. Click to Find ContraFect decision makers emails.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.